rits logo
Wealth Management

Top Unlisted Shares to Watch in 2026

Saxena Varun 4 min read 12 Dec 2025

Imagine stumbling upon a stock like CDSL years before its blockbuster listing, watching it multiply from grey market whispers to a market darling. That’s the thrill of unlisted shares in India right now—especially as we head into 2026, with SEBI easing norms and retail frenzy hitting new highs. If you’re hunting for Top Pre-IPO Shares in India or the best unlisted stocks to buy, this isn’t another generic listicle. From our experience at Rits Capital tracking grey markets for clients, we’ve seen these plays deliver outsized returns when timed right. Today, we’ll dive deep into eight standout unlisted shares 2026 names—NSE, Orbis, Goodluck Defence, CSK, OYO, NCDEX, Hero Fincorp, and PXIL—focusing on why they’re bubbling, their risks, and how to approach them practically. Let’s unpack the stories behind the tickers.

Why 2026 Could Be the Unlisted Breakout Year

The unlisted market isn’t just hype; it’s backed by numbers. Retail participation has exploded, with over a lakh holders in names like NSE alone, pushing NSE unlisted shares price from ₹1,500 to ₹2,400 in months amid IPO buzz. Platforms like Rits capital report 50%+ volume spikes in Q3 FY26, fueled by FII inflows and a pipeline of 200+ listings. But here’s the catch from our desk: not all grey market darlings list smoothly. We’ve advised clients to bucket them into “infra anchors” (exchanges, depositories) versus “growth bets” (consumer, defence), blending stability with alpha.

Common pitfalls? Overpaying on FOMO rallies or ignoring liquidity crunches. Our roadmap: Start with financials, overlay sector tailwinds, then size small (2-5% portfolio) while tracking weekly deals.

Read more about: How India’s only mobile brand dominating International players?

The Crown Jewels: NSE and Exchange Infra Plays

Kick off with National Stock Exchange (NSE), India’s undisputed grey market king. Trading around ₹1950 lately (up 60% YTD), NSE boasts monopoly-like economics in derivatives—90% market share—and PAT growth at 25% CAGR. Its SEBI settlement cleared, Q1 2026 IPO whispers are louder than ever, potentially valuing it at ₹5-6 lakh crore. We’ve positioned client sleeves here for the “BSE parity” rerating, but watch regulatory hiccups; one NoC delay could trim 20% off grey premiums.

Then there’s Power Exchange India (PXIL) and NCDEX, the unsung agri/power infra duo. PXIL’s at ₹525 (double its June stake-sale price), riding market-coupling reforms that promise fairer power trading as renewables surge. NCDEX, around ₹475, flipped to profits via stake sales and agri-deriv volumes up 40%. These aren’t flashy, but from experience, infra like this compounds quietly—think CDSL’s 10x post-listing. Risk? Commodity cycles; hedge with 6-12 month horizons.

Financial Backbone: Orbis and Hero Fincorp

Orbis Financial Corporation flies under radars but shouldn’t. At ₹450, this SEBI-registered custodian (ISIN: INE155K01013) services FPIs and AIFs, with revenue CAGR at 30% and upgrades from CARE AA+. Market cap ~₹6,100 Cr, it’s a “plumbing” play akin to CAMS, growing as demat accounts hit 15 Cr. No IPO yet, but private sales signal momentum. We’ve seen similar backends explode on listing; pro tip: Pair with NSE for capital markets exposure, but demat lock-ins mean patience is key.

Hero Fincorp (₹1,195) brings NBFC muscle. Hero Moto’s finance arm scaled retail lending amid two-wheeler booms, posting 20% AUM growth. Unlisted premiums reflect pre-IPO buzz, but watch asset quality—NPAs ticked up in festive slumps. From our client audits, these steady compounders suit conservative sleeves, outperforming in bull runs but lagging cyclicals.

High-Octane Growth: Defence, Sports, and Hospitality

Goodluck Defence & Aerospace is pure adrenaline. At ₹375-390 (lot 1000, ISIN: INE0S7401019), this Goodluck India subsidiary pumps precision tubes for BrahMos and artillery, debt-free with marquee orders. Defence capex at ₹6.2 lakh Cr in Budget 2026 juices it, but high P/E (1000x) screams valuation risk. We’ve stress-tested these for M&A upside; enter on dips below ₹350, exit at IPO pop.

Chennai Super Kings (CSK) Sports IP gold. The IPL cash machine (zero debt, rising PAT from media rights) trades hot in grey markets, fueled by franchise valuations doubling to ₹10,000 Cr+. Fans drive liquidity, but it’s sentiment-led—missed playoffs could dent 15-20%. Our playbook: Allocate as a 1-2% fun bet, diversifying consumer portfolios.

Finally, OYO at post-profit levels (~₹50-60 adjusted) tells a comeback tale. Asset-light hotels turned EBITDA positive FY25; 2026 listing could unlock 2-3x if travel holds. We’ve navigated its volatility—peak ₹200, trough ₹20—but Zomato parallels suggest multibagger potential. Con: Governance overhangs linger.

Risks, Roadmaps, and Real Returns

Unlisted isn’t set-it-forget-it. Liquidity dries 20-30% on bad news, spreads hit 10-15%, and tax on secondary sales bites at slab rates. From our experience deploying ₹50 Cr+ in greys,

winners follow this: Verify ISINs/demats on CDSL, track RItscapital weekly, cap exposure at 10% total, and ladder exits (50% at IPO pop, rest hold).

Pros: 2-5x listing pops.
Cons: 6-18 month waits, zero dividends. Benchmark against BSE (listed peer) for fair value—NSE at 23x FY26E looks reasonable.

In 2026, these grey market shares 2026 could redefine portfolios, blending infra ballast with thematic pops. NSE and Orbis anchor; Goodluck/CSK/OYO spice it up. Track filings, not forums—discipline turns greys into greens.

Ready to build your watchlist? DM Rits Capital for grey market pricing and sizing strategies tailored to your risk profile.

Faqs:

1. What’s the current NSE unlisted shares price?
Ans: Around ₹1925 as of Dec 2025, up 60% on IPO hopes; check Ritscapital for live quotes. Lot sizes vary 100-500.

2. Is Orbis Financial a good buy among best unlisted stocks?
Ans: Strong at ₹504 if you like CDSL-like growth (30% revenue CAGR), but no IPO timeline—hold 12+ months.

3. Why is Goodluck Defence surging in pre-IPO shares India?
ADefence orders (BrahMos) and ₹1,900 Cr mcap at ₹375-390; high P/E but zero debt signals scalability.

4. Can retail investors buy CSK unlisted shares easily?
Yes, via platforms like Ritscapital from fans, but volatile—target post-IPL dips.

5. OYO unlisted shares: Profit turnaround real?
Yes, FY25 EBITDA positive; 2026 IPO could 2x it, but track governance via annual filings.

6. NCDEX vs PXIL—which for 2026 commodities play?
PXIL (₹345) edges on power reforms; NCDEX (₹475) for agri stability—blend both for infra diversification.

7. Hero Fincorp unlisted price and risks?
₹1195; NPAs a watchout amid lending cycles, but Hero backing adds safety.

8. How to buy these grey market shares 2026 safely?
Demat verify ISINs, use SEBI-registered brokers such as Rits capital, start small, track volumes weekly.

9. Taxes on unlisted shares profits?
STCG 20% (>24m hold), LTCG slab rates; no indexation—consult CA for offsets.

10. Will all these list in 2026?
NSE/PXIL likely Q1-Q2; others FY27. Monitor SEBI filings, not rumors.

Latest Articles

12